{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "GMP cyclique : Questions médicales les plus fréquentes",
"headline": "GMP cyclique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les GMP cyclique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-08",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "GMP cyclique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Nucléotides guanyliques",
"url": "https://questionsmedicales.fr/mesh/D006150",
"about": {
"@type": "MedicalCondition",
"name": "Nucléotides guanyliques",
"code": {
"@type": "MedicalCode",
"code": "D006150",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.695.827.426"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dibutyryl GMP cyclique",
"alternateName": "Dibutyryl Cyclic GMP",
"url": "https://questionsmedicales.fr/mesh/D003995",
"about": {
"@type": "MedicalCondition",
"name": "Dibutyryl GMP cyclique",
"code": {
"@type": "MedicalCode",
"code": "D003995",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.695.827.426.160.325"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "GMP cyclique",
"alternateName": "Cyclic GMP",
"code": {
"@type": "MedicalCode",
"code": "D006152",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ute Römling",
"url": "https://questionsmedicales.fr/author/Ute%20R%C3%B6mling",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Fengyang Li",
"url": "https://questionsmedicales.fr/author/Fengyang%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Zhijian J Chen",
"url": "https://questionsmedicales.fr/author/Zhijian%20J%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology , Howard Hughes Medical Institute , Department of Immunology , and Animal Resource Center , University of Texas Southwestern Medical Center , Dallas 75390-9148 , Texas , United States."
}
},
{
"@type": "Person",
"name": "Roshni R Kharadi",
"url": "https://questionsmedicales.fr/author/Roshni%20R%20Kharadi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, MI, United States."
}
},
{
"@type": "Person",
"name": "George W Sundin",
"url": "https://questionsmedicales.fr/author/George%20W%20Sundin",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, MI, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cost of open access publishing in otolaryngology-head and neck surgery.",
"datePublished": "2022-08-16",
"url": "https://questionsmedicales.fr/article/38059140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/wjo2.78"
}
},
{
"@type": "ScholarlyArticle",
"name": "The gray zone between legitimate and predatory open access scientific publishing.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/37913753",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.24875/RIC.23000191"
}
},
{
"@type": "ScholarlyArticle",
"name": "Choices of immediate open access and the relationship to journal ranking and publish-and-read deals.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36339745",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/frma.2022.943932"
}
},
{
"@type": "ScholarlyArticle",
"name": "The current state of global contribution to open access publishing in neurosurgery: A bibliometric analysis.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/37383467",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bas.2023.101720"
}
},
{
"@type": "ScholarlyArticle",
"name": "COVID-19 and the scientific publishing system: growth, open access and scientific fields.",
"datePublished": "2022-10-10",
"url": "https://questionsmedicales.fr/article/36246788",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11192-022-04536-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Nucléotides",
"item": "https://questionsmedicales.fr/mesh/D009711"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ribonucléotides",
"item": "https://questionsmedicales.fr/mesh/D012265"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nucléotides guanyliques",
"item": "https://questionsmedicales.fr/mesh/D006150"
},
{
"@type": "ListItem",
"position": 6,
"name": "GMP cyclique",
"item": "https://questionsmedicales.fr/mesh/D006152"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : GMP cyclique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur GMP cyclique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur GMP cyclique",
"description": "Comment mesurer le GMP cyclique dans le corps ?\nQuels tests diagnostiques sont utilisés pour le GMPc ?\nLe GMPc est-il impliqué dans des maladies spécifiques ?\nQuels biomarqueurs sont liés au GMPc ?\nComment le GMPc est-il lié à la fonction cardiaque ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Open+Access+Publishing&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur GMP cyclique",
"description": "Quels symptômes sont associés à des niveaux bas de GMPc ?\nDes niveaux élevés de GMPc provoquent-ils des symptômes ?\nLe GMPc affecte-t-il la pression artérielle ?\nQuels symptômes neurologiques sont liés au GMPc ?\nLe GMPc influence-t-il la fonction rénale ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Open+Access+Publishing&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur GMP cyclique",
"description": "Comment maintenir des niveaux sains de GMPc ?\nLe stress affecte-t-il le GMPc ?\nY a-t-il des habitudes à éviter pour le GMPc ?\nL'exercice physique influence-t-il le GMPc ?\nLes suppléments peuvent-ils affecter le GMPc ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Open+Access+Publishing&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur GMP cyclique",
"description": "Quels médicaments augmentent le GMPc ?\nComment le GMPc est-il ciblé dans le traitement des maladies ?\nLe GMPc a-t-il un rôle dans la thérapie génique ?\nQuels effets secondaires sont liés aux traitements du GMPc ?\nLe GMPc est-il impliqué dans des traitements expérimentaux ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Open+Access+Publishing&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur GMP cyclique",
"description": "Quelles complications sont liées à des niveaux anormaux de GMPc ?\nLe GMPc est-il impliqué dans des maladies chroniques ?\nDes niveaux élevés de GMPc peuvent-ils causer des problèmes ?\nLe GMPc est-il lié à des troubles métaboliques ?\nComment le GMPc affecte-t-il la santé mentale ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Open+Access+Publishing&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur GMP cyclique",
"description": "Quels facteurs augmentent le risque d'anomalies de GMPc ?\nL'alimentation influence-t-elle le GMPc ?\nLe vieillissement affecte-t-il le GMPc ?\nLe manque d'exercice influence-t-il le GMPc ?\nLes maladies héréditaires affectent-elles le GMPc ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Open+Access+Publishing&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le GMP cyclique dans le corps ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc peut être mesuré par des tests biochimiques dans des échantillons de sang ou de tissus."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés pour le GMPc ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'immunoessai et des dosages enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il impliqué dans des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de GMPc sont associés à des maladies cardiovasculaires et neurologiques."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont liés au GMPc ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc est souvent mesuré en relation avec d'autres biomarqueurs comme le NO et les prostaglandines."
}
},
{
"@type": "Question",
"name": "Comment le GMPc est-il lié à la fonction cardiaque ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc régule la relaxation des muscles cardiaques, influençant la fonction cardiaque globale."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à des niveaux bas de GMPc ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux bas peuvent entraîner des problèmes de vasodilatation et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Des niveaux élevés de GMPc provoquent-ils des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent causer des maux de tête et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Le GMPc affecte-t-il la pression artérielle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le GMPc joue un rôle dans la régulation de la pression artérielle par la vasodilatation."
}
},
{
"@type": "Question",
"name": "Quels symptômes neurologiques sont liés au GMPc ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de GMPc peuvent être associées à des troubles neurologiques comme l'anxiété."
}
},
{
"@type": "Question",
"name": "Le GMPc influence-t-il la fonction rénale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le GMPc est impliqué dans la régulation de la fonction rénale et de la filtration glomérulaire."
}
},
{
"@type": "Question",
"name": "Comment maintenir des niveaux sains de GMPc ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et l'hydratation peuvent aider à maintenir des niveaux sains."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le GMPc ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut réduire les niveaux de GMPc, affectant la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter pour le GMPc ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et une consommation excessive d'alcool peut aider à maintenir des niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il le GMPc ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut augmenter les niveaux de GMPc et améliorer la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les suppléments peuvent-ils affecter le GMPc ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent influencer positivement les niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le GMPc ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs de la phosphodiestérase, comme le sildénafil, augmentent les niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "Comment le GMPc est-il ciblé dans le traitement des maladies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc est ciblé pour traiter des maladies cardiovasculaires et pulmonaires par des vasodilatateurs."
}
},
{
"@type": "Question",
"name": "Le GMPc a-t-il un rôle dans la thérapie génique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches de thérapie génique visent à moduler les niveaux de GMPc pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont liés aux traitements du GMPc ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des maux de tête, des rougeurs et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il impliqué dans des traitements expérimentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des recherches explorent l'utilisation de GMPc dans des traitements pour des cancers et des maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à des niveaux anormaux de GMPc ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux peuvent entraîner des complications cardiovasculaires et neurologiques graves."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il impliqué dans des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres de GMPc sont associés à des maladies chroniques comme l'hypertension."
}
},
{
"@type": "Question",
"name": "Des niveaux élevés de GMPc peuvent-ils causer des problèmes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent être liés à des troubles de la vision et des migraines."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il lié à des troubles métaboliques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de GMPc peuvent contribuer à des troubles métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Comment le GMPc affecte-t-il la santé mentale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres de GMPc sont associés à des troubles de l'humeur et à l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'anomalies de GMPc ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'obésité et le stress chronique augmentent le risque d'anomalies de GMPc."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le GMPc ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut nuire aux niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "Le vieillissement affecte-t-il le GMPc ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner une diminution des niveaux de GMPc, affectant la santé globale."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice influence-t-il le GMPc ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut réduire les niveaux de GMPc et augmenter les risques cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les maladies héréditaires affectent-elles le GMPc ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques peuvent perturber la signalisation du GMPc, augmentant les risques de complications."
}
}
]
}
]
}
Open access (OA) publishing makes research more accessible but is associated with steep article processing charges (APCs). The study objective was to characterize the APCs of OA publishing in otolaryn...
We conducted a cross-sectional analysis of published policies of 110 OHNS journals collated from three databases. The primary outcomes were the publishing model, APC for original research, and APC wai...
We identified 110 OHNS journals (57 fully OA, 47 hybrid, 2 subscription-only, 4 unknown model). After excluding 12 journals (2 subscription-only, 4 unknown model, 5 OA with unspecified APCs, and 1 OA ...
APCs range from tens to thousands of dollars with limited waivers for authors in LMICs....
Certain open access publishers based on the article processing charges model have found it highly profitable to operate within a gray zone that encompasses both legitimate and predatory publishing pra...
The role of academic journals is significant in the reward system of science, which makes their rank important for the researcher's choice in deciding where to submit. The study asks how choices of im...
•The top three countries made up 56.7% of the total open-access (OA) contributions.•Low and lower-middle-income countries are less than 8% of the total OA publications.•There is a disparity in academi...
We model the growth of scientific literature related to COVID-19 and forecast the expected growth from 1 June 2021. Considering the significant scientific and financial efforts made by the research co...
The online version contains supplementary material available at 10.1007/s11192-022-04536-x....
In two studies, we examined whether open science practices, such as making materials, data, and code of a study openly accessible, positively affect public trust in science. Furthermore, we investigat...
The researchers' aim to quantitatively study the impacts of education, health expenditure, Internet, mobile phone, and open-access articles in medical science on women's health in China. We found that...
Open access (OA) publishing represents an exciting opportunity to facilitate the dissemination of scientific information to global audiences. However, OA publishing is often associated with significan...
In this observational cohort study, we aimed to characterize the landscape of OA publishing in oncology and, further, identify characteristics of oncology journals that are predictive of APCs....
We identified oncology journals using the SCImago Journal & Country Rank database. All journals with an OA publication option and APC data openly available were included. We searched journal websites ...
Of 367 oncology journals screened, 251 met the final inclusion criteria. The median APC was US $2957 (IQR 1958-3450). The majority of journals (n=156, 62%) adopted the hybrid OA publication model and ...
OA publication costs are greater in oncology journals that publish more citable articles, use the hybrid OA model, have a higher IF, and are based in North America or Europe. These findings may inform...
Authors are often faced with the decision of whether to maximize traditional impact metrics or minimize costs when choosing where to publish the results of their research. Many subscription-based jour...
The EMBO Journal and EMBO Reports join EMBO Molecular Medicine, Molecular Systems Biology and Life Science Alliance as Open Access journals from 2024. Full Open Access at EMBO Press completes another ...